Dec. 19, 2007 (dailyindia.com)- Researchers at the University of Alberta have revealed that intensive rehabilitation training for patients with spinal cord injuries can stimulate repair in the brain and spinal cord.
They believe that these new branches growing from severed nerve fibres, along with compensating changes in the brain that would help in restoring hand function and the ability to walk...
By Tom McMillan, Dec. 18, 2007 (Edmonton Journal)- Intensive rehabilitation for those with spinal cord injuries could lead to restored hand function, and even the ability to walk, according to a new University of Alberta study.
The study, published in the November edition of Brain, found that animals who underwent intensive rehabilitation experienced new nerve growth and brain changes that dramatically improved their motor skills...
By Fain Hughes, Dec. 17, 2007 (TradingMarkets.com)- Synthetic Blood International, Inc. (SYBD) has finalized its Phase IIb Oxycyte(TM) clinical trial protocol for the treatment of traumatic brain injury (TBI), and plans to initiate three pre-clinical animal studies in sickle cell disease, spinal cord injury and stroke in the first half of 2008. Oxycyte is the Company's proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute. Previous animal studies have indicated that early intervention with Oxycyte helps to prevent the destruction of nerve cells in spinal cord injuries and provides oxygen to brain tissues in stroke...
By Fain Hughes, Dec. 11, 2007 (TradingMarkets.com)- Cyberkinetics Neurotechnology Systems, Inc. (CYKN) has received a letter from the FDA requesting additional analyses and data regarding its Humanitarian Device Exemption (HDE) marketing application for the Andara(TM) OFS(TM) (Oscillating Field Stimulator) System, a nerve growth stimulator designed as a treatment for acute spinal cord injuries. The FDA has identified additional information related to clinical and engineering data that the Company must provide prior to completion of their review of the device. This could result in a delay of approval for the device until at least the first half of 2008...
Dec. 11, 2007 (wftv.com)- STATINS FOR SPINAL CORDS: Drugs called statins were originally designed to lower cholesterol. Since their approval, statins have been studied to treat everything from Alzheimer's disease to multiple sclerosis for their effect on inflammation, and researchers continue to find new uses for the drug.
Now, researchers at the Medical University of South Carolina have found statins should help people with spinal cord injuries recover...
Dec. 2007 (The New York Academy of Sciences)- he eighth in this series of Annals volumes brings together clinical and basic science researchers from several disciplines in a common forum to address various approaches to neuroprotection.
Topics covered include the following: clinical implications of neuroprotection...
Dec. 13, 2007 (ScienceDaily)- Research reported December 11 in the journal Advanced Materials describes a potentially promising strategy for encouraging the regeneration of damaged central nervous system cells known as neurons.
The technique would use a biodegradable polymer containing a chemical group that mimics the neurotransmitter acetylcholine to spur the growth of neurites, which are projections that form the connections among neurons and between neurons and other cells...
By Shabi Guptha, Dec. 4, 2007 (American Chronicle)- Sports injuries and car accidents, among other injuries, can cause spinal cord injury. The range of spinal cord injury is wide. Some of these injuries are fairly minor and will heal well with a limited amount of physiotherapy, while others need physiotherapy for the rest of their lives...